Amyloid Specific Monoclonal Antibodies
About the Research Project
Program
Award Type
Standard
Award Amount
$199,691
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
A2001068
Summary
Amyloid fibrils are intermediate structures formed during the assembly of the polymeric amyloid fibrils and are central to the mechanism of AD, yet we know very little about their structure. Dr. Wetzel is using two monoclonal antibodies with the ability to bind to amyloid fibrils in order to study their structure. There are antibodies that bind to amyloid fibrils through highly specialized surfaces that fit together with the fibrils like a hand in a glove. Dr. Wetzel is using a number of methods to learn more about the structures of these antibodies, since they will indirectly provide an understanding of fibril structure. In other words, by knowing what the glove looks like, Dr. Wetzel can build a model for the hand that fits into that glove. These antibodies will also be used to study different biochemical steps in the formation of larger aggregates of amyloid from smaller fibril subunits. This research could help to demonstrate the importance of particular forms of amyloid in AD, and lead to the development of a tool by which these important forms can be detected and measured in patients. This could then play an important role in the search for a vaccine against Alzheimer’s.
Related Grants
Alzheimer's Disease Research
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Alzheimer's Disease Research
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Alzheimer's Disease Research
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center